These findings support our hypothesis and suggest that CRHR2high CRC tumors with low Ucn2 expression levels may be more resistant to inflammatory signals such as IL-6 provided and acting via autocrine, or paracrine pathways. The gene discussed is UCN2; the disease is colorectal carcinoma.